[Federal Register Volume 75, Number 196 (Tuesday, October 12, 2010)]
[Notices]
[Pages 62554-62559]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-25427]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Statement of Organization, Functions, and Delegations of
Authority
Part C (Centers for Disease Control and Prevention) of the
Statement of Organization, Functions, and Delegations of Authority of
the Department of Health and Human Services (45 FR 67772-76, dated
October 14, 1980, and corrected at 45 FR 69296, October 20, 1980, as
amended most recently at 75 FR 59277-59278, dated September 25, 2010)
is amended to reflect the reorganization of the National Center for
HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Office of Infectious
Diseases, Centers for Disease Control and Prevention.
Section C-B, Organization and Functions, is hereby amended as
follows:
Delete in its entirety the function statements for the National
Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (CJV) and
the Office of the Director (CJV1) and insert the following:
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB
Prevention (CJV). The National Center for HIV/AIDS, Viral Hepatitis,
STD, and TB Prevention (NCHHSTP) maximizes public health and safety
nationally and internationally through the elimination, prevention, and
control of disease, disability, and death caused by Human
Immunodeficiency Virus Infection/Acquired Immunodeficiency Syndrome
(HIV/AIDS), non-HIV retroviruses, viral hepatitis, other sexually
transmitted diseases (STDs), and tuberculosis (TB). In carrying out its
mission, NCHHSTP: (1) Builds capacity and enhances public health
infrastructure for preventing and treating HIV/AIDS, viral hepatitis,
STDs, and TB; (2) coordinates activities and programs across CDC and
with other Department of Health and Human Services Operational
Divisions in order to maximize the public health impact of HIV/AIDS,
viral hepatitis, STDs, and TB interventions; (3) conducts surveillance
and research to determine the distribution, determinants, and burden of
HIV/AIDS, viral hepatitis, STDs, and TB; (4) conducts program
evaluation to improve programs and activities relating to the
prevention of HIV/AIDS, viral hepatitis, STDs, and TB, and determine
their impact; (5) provides reference laboratory and clinical diagnostic
services for HIV/AIDS, viral hepatitis, STDs, and TB to relevant
stakeholders; (6) promotes collaboration and service integration among
HIV/AIDS, viral hepatitis, STDs, and TB programs; (7) engages external
partners to develop and implement effective HIV/AIDS, viral hepatitis,
STDs, and TB policies, research, and programs; (8) engages partners, to
promote health equity and reduce health disparities among those
affected by HIV/AIDS, viral hepatitis, STDs, and TB; (9) provides
technical assistance and training in the diagnosis, treatment, and
prevention of HIV/AIDS, viral hepatitis, STDs, and TB; (10) conducts
public health communication activities to disseminate research findings
and increase awareness of HIV/AIDS, viral hepatitis, STDs, and TB; (11)
conducts operational, behavioral, and biomedical research to improve
the distribution, diagnosis, prevention, and control of HIV/AIDS, viral
hepatitis, STDs, and TB; (12) provides scientific leadership regarding
public health ethics and protection of human subjects linked to HIV/
AIDS, viral hepatitis, STDs, and TB; (13) translates research findings
into public health practice and policy for HIV/AIDS, viral hepatitis,
STDs, and TB prevention; (14) plans, coordinates, and guides programs
and activities with external partners, federal agencies, and other
organizations related to HIV/AIDS, viral hepatitis, STDs, and TB
prevention, care, and treatment; (15) leads and participates in the
development, implementation, and evaluation of policies and guidelines
related to HIV/AIDS, viral hepatitis, STDs, and TB; (16) provides
scientific leadership regarding screening, treatment, immunization, and
other prevention interventions relevant to HIV/AIDS, viral hepatitis,
STDs, and TB; (17) assures all public health decisions are based on the
highest quality scientific data, openly and objectively derived; (18)
provides leadership to assist international partners in establishing
and maintaining, HIV/AIDS, viral hepatitis, STDs, and TB screening,
treatment,
[[Page 62555]]
immunization, and other prevention and control programs; (19) ensures
that programmatic and scientific activities are aligned with, and in
support of, CDC's overall mission, goals, and strategic imperatives;
(20) allocates and tracks CDC resources and contributes to the
development of CDC's short-, medium- and long-term strategic plans for
preventing the spread of HIV/AIDS, viral hepatitis, STDs, and TB; (21)
collaborates with other federal agencies, domestic and international
governmental and non-governmental organizations to advance CDC and
NCHHSTP health protection goals; and (22) coordinates oversight of the
NCHHSTP Federal Advisory Committees.
Office of the Director (CVJ1). (1) Provides leadership and guidance
on the development of goals and objectives, policies, program planning
and development, and program management and operations of the
activities of NCHHSTP and manages, directs, coordinates, and evaluates
the center's activities; (2) plans and coordinates the annual program
planning process; (3) coordinates with Office of the Director (OD),
Centers/Institute/Offices (CIOs), and divisions in determining and
interpreting operating policy and in ensuring their respective
management input for specific program activity plans; (4) facilitates
CIOser linkages between HIV, non-HIV retroviruses, STDs, viral
hepatitis, and TB, surveillance activities and prevention programs at
all levels, and facilitates collaboration, integration, and multi-
disciplinary approaches to enhance the effectiveness of HIV, STD, viral
hepatitis, and TB prevention programs; (5) facilitates collaboration
among, and integration of, science and prevention programs throughout
NCHHSTP and enhances the coordination and integration of HIV, STD,
viral hepatitis, and TB prevention services for individuals and
populations at increased risk for more than one of these infections;
(6) coordinates the integration of CDC funding of state and local
health departments for HIV, STD, viral hepatitis, and TB prevention;
(7) maximizes center-wide collaboration to promote and support Program
Collaboration and Service Integration (PCSI) in state and local HIV/
AIDS, viral hepatitis, STD and TB programs to increase efficiencies and
provide comprehensive evidence based prevention services to impacted
populations; (8) develops partnership objectives and strategies for
advancing center priorities (e.g., on cross-cutting functions PCSI,
reducing health disparities, etc.) and leverages OD resources to
address these objectives and strategies; (9) coordinates and tracks
health equity science and program activities within the center; (10)
coordinates and tracks science and program activities that concern or
address social determinants of health within NCHHSTP and other
programs; (11) collaborates with the CDC OD and other CDC components on
health equity activities, and works with the CDC OD to monitor progress
in meeting Executive Orders related to improving minority health; (12)
develops partnerships with other federal agencies and nongovernmental
organizations working on similarly-affected populations; (13) supports
research, surveillance, education, training, and program development to
achieve health equity and reduce health disparities; (14) sponsors
workgroups, meetings, and conferences related to health equity; (15)
promotes a diverse public health workforce through internships,
fellowships, training programs, and other activities; (16) ensures
process consistency for laboratory related functions within NCHHSTP and
across the CIOs; (17) facilitates cross-center decision-making
regarding laboratory activities; (18) monitors the performance of
funded extramural research projects in the areas of HIV/AIDS, viral
hepatitis, STD and TB; (19) collaborates with other federal agencies to
advance prevention through healthcare; (20) coordinates and supports
cross-cutting strategic initiatives in support of NCHHSTP divisions and
partners; and (21) works across the agency to advance prevention
priorities.
After the functional statement for the Office of the Director
(CVJ1), insert the following:
Office of the Associate Director for Science (CVJ12). (1) Ensures
process consistency for science across the CIOs; (2) facilitates cross-
center decision-making regarding science; (3) facilitates communication
regarding scientific and programmatic services across the Office of
Infectious Diseases (OID); (4) conducts necessary regulatory and
ethical reviews for activities involving human participants, including
determining whether an activity includes research, includes human
subjects, is exempt or requires Institutional Review Board approval,
and whether an exception is needed to the Public Health Service HIV
policy; (5) reviews funded activities for application of human research
regulations; (6) reviews, approves, and tracks research protocols,
clinical investigations, and the Food and Drug Administration regulated
response activities intended for submission to CDC Human Research
Protections Office; and (7) coordinates and tracks Office of Management
and Budget clearance under the Paperwork Reduction Act.
Informatics Office (CVJ13). (1) Manages all information technology
(IT) project costs, schedules, performances, and risks; (2) provides
expertise in leading application development techniques in information
science and technology to effect the best use of resources; (3)
performs technical evaluation and integrated baseline reviews of all
information systems' products and services prior to procurement to
ensure software purchases align with NCHHSTP strategy; (4) provides
access to quality data in support of programmatic data analysis; (5)
coordinates all enterprise-wide IT security policies and procedures
with key agency offices; (6) ensures operations are in accordance with
CDC Capital Planning and Investment Control guidelines; (7) ensures
adherence to CDC enterprise architecture guidelines and standards; (8)
consults with users to determine IT needs and to develop strategic and
action plans; and (9) participates in the evolution, identification,
development, or adoption of appropriate informatics standards.
Extramural Research Program Office (CVTJJ14). (1) Serves as the
focal point for the OID for implementing policies and guidelines for
the conduct of the peer review of infectious disease extramural
research grant proposals and subsequent grant administration; (2)
coordinates and conducts in-depth external peer review and secondary
program relevance review of extramural research applications by use of
consultant expert panels; (3) makes recommendations to the appropriate
infectious disease center director on award selections and staff
members serve as the program officials in conjunction with CDC grants
management and policy officials to implement and monitor the
scientific, technical, and administrative aspects of awards; (4)
facilitates scientific collaborations between external and internal
investigators; (5) disseminates and evaluates extramural research
progress, findings, and impact; and (6) coordinates and executes
objective review, including the special emphasis panel (SEP) process
for funding of CDC infectious disease non-research grants and
cooperative agreements.
Office of Management and Program Support (CVJ15). (1) Helps
implement and enforce management and operations policies and guidelines
developed by
[[Page 62556]]
federal agencies, DHHS, and Staff Service Offices (SSO); (2) plans,
develops, implements, and provides oversight and quality control for
center-wide policies, procedures, and practices for administrative
management and acquisition and assistance mechanisms, including
contracts, memoranda of agreement, and cooperative agreements; (3)
provides management and coordination of NCHHSTP-occupied space and
facilities; (4) supplies technical guidance and expertise regarding
occupancy and facilities management to emergency situations; (5)
provides oversight and management of the distribution, accountability,
and maintenance of CDC property and equipment; (6) provides oversight,
quality control, and management of NCHHSTP records; (7) serves as lead
and primary contact and liaison with relevant SSO on all matters
pertaining to the center's procurement needs, policies, and activities;
(8) develops, reviews, and implements policies, methods and procedures
for NCHHSTP non-research extramural assistance programs; (9) interprets
general policy directives, proposed legislation, and appropriation
language for implications on management and execution of center's
programs; (10) provides consultation and technical assistance to
NCHHSTP program officials in the planning, implementation, and
administration of assistance programs; (11) develops and implements
objective review processes, including use of SEP process for
competitive application cycles; (12) oversees the formulation of the
NCHHSTP budget and responds to inquiries related to the budget; (13)
provides technical information services to facilitate dissemination of
relevant public health information and facilitates collaboration with
national health activities, CDC components, other agencies and
organizations, and foreign governments on international health
activities; (14) provides oversight for the programmatic coordination
of HIV, STD, viral hepatitis, and TB activities between NCHHSTP and
other CIOs; develops recommendations to the CDC Director as the lead
CIO for these programs for the distribution of HIV, STD, viral
hepatitis, and TB funds CDC-wide; (15) provides guidance and
coordination to divisions on cross-divisional negotiated agreements;
(16) facilitates state and local cross-divisional issues identification
and solutions; (17) in coordination with the Office of Program Planning
and Policy Coordination, responds to Congress as needed; (18) serves as
NCHHSTP liaison to relevant SSOs for all matters related to financial
management; (19) serves as focal point for emergency operations and
deployment; (20) manages and coordinates workforce development and
succession planning activities within NCHHSTP in collaboration with
internal and external partners, and coordinates the recruitment,
assignment, technical supervision, and career development of staff with
emphasis on developing and supporting diversity initiatives and equal
opportunity goals; (21) facilitates the assignment of field staff in
accordance with CDC and NCHHSTP priorities and objectives and
reassesses the role of NCHHSTP field staff assignees to state and local
health jurisdictions; and (22) provides center-wide training to
supervisors, managers and team leaders.
Office of Program Planning and Policy Coordination (CVJ16). (1)
Identifies program priorities through strategic planning and other
processes as appropriate; (2) oversees the development of the center's
performance plan and performance reports to ensure accountability and
improve programs and activities; (3) coordinates with the center
director and management officer the formulation of the NCHHSTP budget;
(4) liaises with the CDC SSOs on Congressional, legislative, and other
inquiries; (5) maintains liaison with Congress on matters including
appropriations, legislative bill tracking, and legislative requests,
testimony for hearings, congressional inquiries, etc.; (6) develops
policy- and program-related materials, and talking points; (7) oversees
the preparation and routing of controlled correspondence; (8) maintains
liaison with key CDC offices and individuals working on public health
policies and legislative issues; (9) serves as liaison to governmental
and nongovernmental partners on policy-related issues; (10) oversees
priority issues management and proactive and reactive strategic media
efforts; (11) conducts environmental analysis in response to short-term
issues to be shared with leadership and program managers; (12) works
with the Health Communication Science Office to coordinate
communication strategy and manage short-term issues; (13) formulates
strategic media objectives for advancing program priorities and
addressing identified long-range issues; and oversees the
implementation of strategic media plans through several functional
areas; (14) develops and implements all proactive media outreach and
reactive media responses for the center; (15) provides media training
and technical assistance, as appropriate; and (16) serves as liaison to
key offices for obtaining CDC and HHS media clearance on products/
activities.
Health Communication Science Office (CVJ17). (1) Serves as the
principal advisor to NCHHSTP on communication and marketing science,
research and practice; (2) provides oversight to ensure the quality and
science of health communication and marketing campaigns and products
created by NCHHSTP and its divisions; (3) serves as NCHHSTP clearance
office for health communication campaigns and products; develops and
manages clearance systems; (4) provides strategic planning and
coordination for NCHHSTP communication and marketing programs in
collaboration with OD and division-level staff; (5) collaborates with
NCHHSTP policy and media relations staff to ensure consistent and
timely translation of center-specific health information; (6) executes
communication activities to support strategic goals and objectives of
the NCHHSTP OD and activities to support division-level programs; (7)
coordinates and provides center input on communication activities; (8)
coordinates CDC and NCHHSTP brand management; (9) provides oversight
and consultation on partnership development and partner/stakeholder
communication; (10) develops and manages partner relationships in
collaboration with NCHHSTP divisions and CDC CIOs; (11) coordinates
partnership strategies across NCHHSTP divisions; (12) manages
communication infrastructure for NCHHSTP partnerships; (13) oversees
management, policy guidance, and governance of NCHHSTP digital channels
and Web sites per HHS and CDC policy for the use of communication
technologies; (14) provides coordination and conducts activities to
support NCHHSTP's presence on networked media, such as social and
mobile media; and (15) collects/analyzes user data/metrics from
communication channels and technologies to assess system performance,
usability, accessibility, and usefulness.
Delete items (15) and (16) of the functional statement for the
Office of the Director (CVJB 1), Division of HIV/AIDS, Prevention-
Intervention Support (CVJB), and insert the following: (15)
Collaborates with other branches, divisions, and CIOs to synthesize HIV
prevention research findings and translate them into prevention
practice; and (16) collaborates, as appropriate, with other divisions
and offices of NCHHSTP, and with other CIOs throughout CDC in carrying
out these activities.
[[Page 62557]]
Delete item (1) of the functional statement for the Prevention
Program Branch (CVJBC), and insert the following: (1) In collaboration
with state and local public health and non-governmental national/
regional and local partners, CIOs, and other federal agencies, develops
and implements programs, policies, and activities that enable and
mobilize affiliates and communities to become involved with, and
support, local and statewide strategic community planning that improves
HIV prevention programs and activities.
Delete in its entirety the title and function statement for the
Program Evaluation Research Branch (CVJBD), and insert the following:
Program Evaluation Branch (CVJBD). (1) Evaluates the effectiveness
and impact of HIV prevention interventions, strategies, policies, and
programs as practiced or implemented by CDC-funded public health
agencies and organizations at the national/regional and state/local
levels; (2) collaborates within DHAP, with HIV prevention program
grantees, and with other national partners to systematically collect,
process, and use HIV prevention program data for program planning and
improvement; (3) collaborates in the conduct of evaluation research
activities and economic evaluations of HIV prevention activities; (4)
seeks to advance the methodology of HIV prevention evaluation through
CDC evaluation activities and with the field of program evaluation more
broadly; and (5) collaborates with other branches as they develop,
test, and disseminate models for quality assurance of programs and
services.
Delete in its entirety the title and function statement for the
Technical Information and Communications Branch (CVJBG), and insert the
following:
Prevention Communications Branch (CVJBG). (1) Implements science
and evidence based HIV/AIDS communication programs and approaches that
target opinion leaders, stakeholders, persons at risk for and living
with HIV/AIDS and the general public; (2) systematically translates and
disseminates science based messages through multiple communication
channels; (3) effectively implements agenda setting and mobilization
efforts; and (4) implements efficient internal communication approaches
targeting DHAP staff.
Delete items (3) and (10) of the functional statement for the
Office of the Director (CVJC 1), Division of HIV/AIDS, Prevention-
Surveillance and Epidemiology (CVJC) and insert the following: (3)
Provides leadership in developing research in epidemiology,
surveillance, and other scientific aspects of HIV/AIDS prevention, and
in coordinating activities between the division and other NCHHSTP
divisions, CIOs, and national-level prevention partners who influence
HIV/AIDS prevention programs involved in HIV/AIDS investigations and
research; and (10) collaborates, as appropriate, with other divisions
and offices of NCHHSTP, and with other CIOs throughout CDC.
After item (10) of the functional statement for the Office of the
Director (CVJD1), Division of Sexually Transmitted Disease Prevention
(CVJD), add the following: and (11) manages the Tuskegee Participants
Health Benefits Program.
After the functional statement for the Statistics and Data
Management Branch (CVJDH), add the following:
Field Services Branch (CVJDJ). (1) In collaboration with the
Program and Training Branch assigns Public Health Advisors to state and
local health departments; (2) provides state and local health
departments technical assistance with the development and
implementation of strategies for addressing the STD burden; (3)
provides state and local health departments assistance with developing,
implementing and evaluating core public health activities to reduce the
incidence, strengthen public, private clinical and community-based
partnerships; and (4) promotes and enhances capacity-building within
state and local health departments through consultation, demonstration
and technical expertise.
Delete in their entirety the functional statements for the Division
of Tuberculosis and Elimination (CVJE), and Office of Director (CVJE1),
and insert the following:
Division of Tuberculosis Elimination (CVJE). The Division of
Tuberculosis Elimination (DTBE) promotes health and quality of life by
preventing, controlling, and eventually eliminating TB from the United
States (U.S.), and by collaborating with other countries and
international partners in controlling TB worldwide. In carrying out its
mission, the division conducts the following activities under each
focus area: (1) Administers and promotes a national program for the
prevention, control, and elimination of TB; (2) supports a nationwide
framework for surveillance of TB and evaluation of national TB
prevention and control program performance; (3) provides programmatic
consultation, technical assistance, and outbreak response assistance to
international, state, and local TB programs; (4) co-chairs and
coordinates administrative support for the Federal TB Task Force, and
supports and collaborates with the National Tuberculosis Controllers
Association and the Tuberculosis Education and Training Network to
promote effective national communications and coordinated feedback on
urgent policy and program performance issues; (5) supports development
of TB patient education materials and interventions, capacity
development, and access to medical consultation; (6) provides national
and supranational reference laboratory function for identification,
drug susceptibility testing of Mycobacterium tuberculosis; (7) fosters
patient-centered measures, including directly-observed therapy, to
promote adherence with long-term treatment for improvements in well-
being and interruption in community transmission of M tuberculosis; (8)
promotes targeted testing of idemiologically-defined at-risk
populations and treatment of persons with latent TB; (9) conducts
epidemiologic, laboratory, behavioral, health systems, and clinical
research; (10) supports patient and provider research to identify
barriers and facilitators to TB services; (11) supports multicenter
consortia for epidemiologic, laboratory, diagnostics, clinical, and
vaccine development research; (12) develops and applies mathematical TB
transmission models to forecast future incidence and prevalence trends;
(13) provides leadership and formulates national and global policies
and guidelines; (14) provides technical supervision and training to
federal assignees working in international, state, and local TB control
programs; (15) develops training and educational materials, and
provides technical assistance on communications and training needs;
(16) participates in the development of policies and guidelines for TB
prevention and control within populations at high risk, such as persons
infected with HIV or racial and ethnic minorities; (17) provides
programmatic consultation, technical assistance, and outbreak response
assistance to other countries by collaborating with national and
international partners; (18) supports technical activities and
operational research to reduce TB in foreign-born populations; (19)
provides leadership and technical support to the global health
initiatives for the prevention and control of TB and drug-resistant TB;
(20) provides leadership and technical support to the World Health
Organization (WHO)-hosted Stop TB
[[Page 62558]]
Partnership for implementation of the Global Plan to Stop TB and
Millennium Development Goals; (21) monitors progress and trends towards
TB elimination; (22) monitors progress towards CDC, Healthy People
2010, and the Government Performance Results Act goals; (23) provides
progress reports to, and solicits advice from, the Advisory Council for
the Elimination of Tuberculosis (ACET); and (24) facilitates
partnerships with affected communities, nongovernmental, professional,
and global organizations.
Office of the Director (CVJE1). (1) Provides leadership and
guidance in program planning and management, policy formulation, and
development of training, surveillance, and research programs in TB; (2)
directs and evaluates the operations of the division; (3) establishes
contact with, and promotes TB activities of, other national and
international organizations which have an important role to play in
achieving TB elimination; (4) coordinates administrative and logistical
support services for the division; (5) provides consultation and
assistance in writing reports for presentation at local, regional,
national, and international scientific meetings and for publication in
scientific journals; (6) coordinates and tracks materials for purposes
of clearance and approval for publications and presentations; (7)
presents findings at national and international scientific meetings;
(8) presents division overview at the ACET meetings; (9) collaborates
and coordinates division activities with other components of NCHHSTP
and CDC; (10) provides technical support to ACET; (11) provides
administrative and technical support for the Stop TB USA (previously
the National Coalition for the Elimination of Tuberculosis) and the
Federal TB Task Force; and (12) provides leadership and technical
expertise to the global Stop TB partnership.
Delete in its entirety the functional statement for the
Communications, Education, and Behavioral Studies Branch (CVJEB), and
insert the following:
(1) Provides technical assistance to health departments and other
health care providers in assessing and meeting their TB training,
education, and communication needs; (2) provides technical expertise to
assess the impact of training and education activities by health
departments; (3) provides technical assistance to health departments
and other TB health care providers regarding behavioral studies
research and intervention development; (4) collaborates with the WHO,
the World Bank, the International Union Against Tuberculosis and Lung
Diseases (IUATLD), United States Agency for International Development
(USAID), and others, in assessing and meeting TB training, education,
and communication needs in other countries; (5) provides consultation
and assistance in coordinating TB training, education, behavioral
studies and interventions, and communication activities carried out by
other CDC programs, Regional Training and Medical Consultation Centers,
and Stop TB USA members, and develops, markets, and maintains
electronic mailing lists for persons with TB-related education,
training, and communication responsibilities; (6) develops, plans, and
coordinates agendas necessary to conduct TB conferences and workshops
sponsored by the division; (7) provides DTBE coordination and oversight
and technical information for CDC INFO; (8) organizes and maintains
scientific and non-scientific information resources related to TB; (9)
conducts formative research and evaluation on approaches to patient,
provider, and public education, and conducts research on individual and
social factors affecting health-care seeking behavior and treatment
outcomes related to TB; (10) based on research findings, develops
behavioral interventions targeted to health care providers, persons
with or at risk for TB, and other high-risk populations; (11) provides
consultation to national and international organizations on behavioral
research needs and study designs; on the technical transfer of
behavioral research findings into TB program practice and TB training
and educational strategies; and provides consultation, technical
assistance, and coordination to other branches within the division
regarding development and implementation of behavioral interventions
and training for branch specific activities such as Report of Verified
Case of Tuberculosis, Aggregate Reports for Program Evaluation, and
surveillance activities; (12) presents findings at national and
scientific meetings and develops, disseminates, and evaluates training
and educational materials and courses providing TB information to the
scientific and public health communities, as well as the general
population; (13) conducts training and education needs assessments;
identifies resources available for health department TB control
officers and senior managers, TB nurse consultants, TB training and
education directors and for senior staff carrying out TB activities in
other programs or facilities serving persons at high risk for TB; and
develops, conducts, and coordinates training courses on TB for state
and big city TB program managers and nurse consultants; (14) based on
needs assessments, develops and conducts or coordinates training
courses and materials for staff who train and/or supervise front-line
TB program staff (15) provides oversight in the planning, coordination,
and maintenance of the division's Internet and Intranet Web sites; (16)
conducts and/or coordinates communications programs designed to build
public support and sustain public interest and commitment to the
elimination of TB; (17) conducts communications research and identifies
communications resources available for health department TB control
officers and senior managers, TB nurse consultants, and for senior
staff carrying out TB activities in other programs or facilities
serving persons at high risk for TB; (18) coordinates graphic support
to the division and senior field staff; (19) provides coordination and
oversight for division responses and relations with the media and
public and serves as point of contact for telephonic, written, and
electronic (e-mail) requests for information from the media and public;
(20) develops, coordinates, and staffs the divisions exhibit booth at
conferences/meetings; (21) provides oversight and coordination for TB
related voice and Web-based TB information, training, and education
resources; (22) maintains inventory of TB training opportunities and
coordinates with employees and supervisors for training necessary to
carry out their duties; and (23) presents communications issues to ACET
and at national and international scientific meetings.
Delete in its entirety the title and function statement for the
Clinical and Health Systems Research Branch (CVJEE), and insert the
following:
Clinical Research Branch (CVJEE). (1) Assesses the need for and
conducts studies of new or existing drugs and regimens used in the
prevention and treatment of TB, including dosage, duration,
pharmacokinetics and toxicity; (2) supports the TB Trials Consortium in
the conduct of studies of new treatments for active TB and latent TB
infection; (3) supports coordinated and standardized data management
for branch research, and serves as the Data and Coordinating Center for
the TB Trials Consortium, collaborating as needed with both internal
and external partners; (4) collaborates with private and public
institutions in the area of vaccine development; (5) provides clinical
support and oversight for the
[[Page 62559]]
distribution of investigational drugs for the treatment and prevention
of TB by CIOs/Scientific Resources/Drug Service; (6) assesses the need
for and conducts clinical and field trials of more specific and rapid
tests to diagnose active TB and latent TB infection and to identify
drug-resistant TB in collaboration with the Laboratory Branch; (7)
collaborates with and provides consultation and technical assistance to
national and international organizations on the design and conduct of
clinical trials and research needs; (8) conducts, participates in, and
collaborates with other DTBE units in research on clinical,
epidemiologic, immunologic and genetic aspects of TB prevention and
control; (9) collaborates in contact investigation research with other
branches and local programmatic areas; (10) conducts multidisciplinary
studies (including the analysis of behavioral, economic, and
epidemiologic factors) of health care systems to assess the cost,
effectiveness, and impact of public health policies, programs, and
practices on TB outcomes to further the goal of TB elimination in the
U.S., and targets these studies toward various populations at high risk
for TB, including persons from high TB prevalent countries, homeless
persons, HIV-infected persons, residents of correctional facilities,
substance abusers, and health care workers; (11) provides consultation
and training to local, state, national, and international
organizations, and to TB program field staff, on design and conduct of
clinical trials, TB therapeutics and diagnostics, health care systems
research needs, decision and economic analyses, evaluation techniques,
qualitative research methods, and research on TB transmission; (12) has
responsibility for divisional engagement in preparing for and
participating in trials of new TB vaccines; (13) reports study results
to public health practitioners through direct communication, articles
in scientific journals and CDC publications, and oral and poster
presentations at national and international scientific meetings; (14)
provides input into statements and guidelines issued by the CDC, the
ACET, and professional organizations; and (15) presents research issues
and findings to ACET and at national and international scientific
meetings.
Delete items (2), (3), (4), and (6) of the functional statement for
the International Research and Programs Branch (CVJEI1D), and insert
the following: (2) Coordinates the assessment of immigration and its
impact on TB patterns in the U.S. and assists with the evaluation of
overseas TB screening procedures for immigrants and refugees; (3)
conducts and coordinates operational research and demonstration
projects to improve both the overseas screening for TB of immigrants
and refugees and the domestic follow-up of those entering with
suspected TB (in collaboration with other CIOs); (4) promotes the
improved recognition and management of TB among the foreign-born
through epidemiological analyses of national TB surveillance data and
special studies on the U.S./Mexico border and in countries contributing
to foreign-born TB cases in the U.S.; (6) collaborates with the nation
of Botswana, WHO, the World Bank, IUATLD, USAID, and others, to conduct
investigations into the diagnosis, management, and prevention of TB in
persons with and without HIV infection.
Delete in its entirety the title and function statement for the
Mycobacteriology Laboratory Branch (CVJEJ), and insert the following:
Laboratory Branch (CVJEJ). (1) Serves as the national reference
laboratory in support of the mission of DTBE, fulfilling public health
function in leadership, clinical and consultative service, and
research; (2) provides laboratory support for epidemic investigations,
surveillance activities, and special studies of TB, in collaboration of
other branches; (3) administers contracts to provide Mycobacterium
tuberculosis genotyping, maintains a national database of genotypes,
and conducts operational research to implement genotyping; (4) develops
and evaluates new methods to subtype M tuberculosis for epidemiologic
studies; (5) serves as primary CDC focus for diagnostic laboratory
services for TB; (6) administers grants and cooperative agreements with
states and others to upgrade laboratory activities and provide special
services; (7) provides reference diagnostic services, consultation,
technical assistance, and training to state, federal, and municipal
public health laboratories; (8) provides laboratory support, reference
services, assessment, consultation, and training for CDC's
international TB activities; (9) develops, evaluates, or improves
conventional and molecular methods for the detection, classification,
identification, characterization, and susceptibility testing of M
tuberculosis; (10) conducts studies to define the role of bacterial
virulence factors, host factors, and pathogenic and immunologic
mechanisms in disease processes and protective immunity in
mycobacteria, and develops, evaluates, and improves immunologic methods
for the diagnosis and prevention of TB; (11) develops tissue culture
and animal models of TB and conducts studies on chemotherapy,
immunotherapy, pathogenesis, pathology, and vaccines for TB; (12)
prepares manuscripts for publication in scientific journals; (13)
presents findings at national and international scientific meetings;
(14) supervises and trains fellows in temporary or multi-year
educationally-based programs in endeavors related to the mission of the
branch; and (15) presents laboratory issues to ACET and at national and
international scientific meetings.
Dated: September 27, 2010.
William P. Nichols,
Chief Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2010-25427 Filed 10-8-10; 8:45 am]
BILLING CODE 4160-18-M